Anagrelide and interstitial lung disease Patient Reports February 11, 2012

Anagrelide Side Effects Report #5574013-0
Anagrelide side effect was reported by a Physician from GERMANY on Dec 11, 2007. Female patient, 73 years of age, was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: interstitial lung disease, pulmonary embolism , pulmonary fibrosis , renal impairment. Anagrelide dosage: 2.5 MG DAILY, ORAL, 2.5 MG DAILY, ORAL. During the same period patient was treated with BUSULFAN, HYDROXYUREA. Patient was hospitalized. Patient died on 11/03/2006.

Anagrelide Side Effects Report #5885651-X
Anagrelide side effect was reported by a Physician from GERMANY on Aug 28, 2008. Female patient, 73 years of age, was diagnosed with essential thrombocythaemia and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: embolism, interstitial lung disease, pulmonary fibrosis , renal impairment. Anagrelide dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with BUSULFAN, HYDROXYUREA. Patient was hospitalized. Patient died on 11/03/2006.

Anagrelide Side Effects Report #4809258-8
Anagrelide side effect was reported by a Health Professional from FRANCE on Oct 13, 2005. Male patient, 72 years of age, was treated with Anagrelide. After drug was administered, patient experienced the following side effects: chlamydia serology positive, interstitial lung disease, pneumonia . Anagrelide dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Anagrelide Side Effects Report #5866491-4
Anagrelide side effect was reported by a Consumer or non-health professional from CANADA on Aug 12, 2008. Female patient was diagnosed with pneumonitis and was treated with Anagrelide. After drug was administered, patient experienced the following side effects: fungal infection , hyperglycaemia, interstitial lung disease, oedema peripheral, opportunistic infection, pneumonia aspiration, pneumonitis, pulmonary alveolar haemorrhage. Anagrelide dosage: 0.5 MG; 3 TIMES A DAY. During the same period patient was treated with PREDNISONE, HYDROXYCARBAMIDE, DALTEPARIN, CLOPIDOGREL, ASPIRIN, RAMIPRIL, METOPROLOL TARTRATE, SIMVASTATIN. Patient died.